文献速递中医妇科中药与中成药合理使用

补肾调经方通过调控KLF4介导线粒体功能与转录活性促进子宫内膜血管生成改善内膜容受性

Bushen Tiaojing Decoction promotes endometrial angiogenesis to improve endometrial receptivity by regulating KLF4-mediated mitochondrial function and transcription activity.
PubMed 文献 · J Ethnopharmacol · 2025-09-29

该研究探讨补肾调经方(BSTJD)改善子宫内膜容受性的机制,采用控制性超促排卵(COH)小鼠模型及人子宫内膜微血管内皮细胞(HEMECs),发现BSTJD可促进子宫内膜血管生成、提高胚胎着床数,其机制涉及KLF4介导的线粒体功能改善及KLF4-GCN5复合物增强VEGFA转录。

要点

  • BSTJD可促进COH小鼠子宫内膜血管生成,提高胚胎着床数。
  • BSTJD通过改善线粒体功能促进HEMECs增殖迁移并抑制凋亡。
  • BSTJD激活ERK通路促进KLF4-GCN5复合物形成,反式激活VEGFA表达。

核心结论

  • BSTJD通过激活KLF4改善子宫内膜容受性,既通过改善线粒体功能促进血管生成,又通过增强KLF4-GCN5互作激活VEGFA转录,从而提高胚胎着床数。

研究设计与样本

  • 建立控制性超促排卵(COH)小鼠模型并给予BSTJD治疗,评估胚胎着床数及子宫形态变化。
  • 用人子宫内膜微血管内皮细胞(HEMECs)给予BSTJD含药血清或过表达KLF4的腺病毒处理,进行管腔形成实验、线粒体功能评估及分子检测。

主要发现

  • BSTJD促进COH小鼠子宫内膜血管生成,改善子宫内膜容受性,增加胚胎着床数。
  • BSTJD协同VEGFA上调KLF4水平,改善线粒体功能,从而增加HEMECs增殖和迁移并减少细胞凋亡。
  • BSTJD通过激活ERK通路促进KLF4-GCN5复合物形成,该复合物被招募至HEMECs中VEGFA启动子的KLF4结合位点,反式激活VEGFA表达,导致子宫内膜血管生成。

临床怎么用

  • BSTJD可能作为改善IVF-ET患者子宫内膜容受性的潜在中药复方,其机制涉及KLF4介导的血管生成与转录调控。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

ETHNOPHARMACOLOGICAL RELEVANCE: Traditional Chinese medicine has numerous advantages in the treatment of infertility. The traditional Chinese herbal formula Bushen Tiaojing Decoction (BSTJD) is widely used for treating infertility, which can effectively promote embryo implantation rate for infertility patients undergoing in vitro fertilization and embryo transfer (IVF-ET) by improving endometrial receptivity. However, the exact mechanism underlying BSTJD-improved endometrial receptivity has not yet been elucidated. AIM OF THE STUDY: Krüppel-like factor 4 (KLF4) is an essential transcription factor that regulates endometrial angiogenesis. This study investigates the effect and mechanism of BSTJD on promoting endometrial angiogenesis involved in KLF4. METHODS: The controlled ovarian hyperstimulation (COH) mouse model was established and treated with BSTJD. Embryo implantation numbers and the changes in uterine morphology were evaluated. Human endometrial microvascular endothelial cells (HEMECs) were treated with BSTJD medicated serum, or adenovirus overexpressing KLF4. Tube formation assay was performed to observe HEMEC tubulogenesis. Mitochondrial function of HEMECs was evaluated. The levels of MMP-9, PCNA, Caspase 3, VEGFA, KLF4, GCN5, and succinylated H3K79 in HEMECs were measured. The KLF4 combined with GCN5 and its succinylation were detected by immunoprecipitation, and their localization was performed for immunofluorescence staining. Chromatin immunoprecipitation assay was performed for KLF4 and succinylated H3K79 enrichments on the VEGFA promoter. RESULTS: BSTJD promoted endometrial angiogenesis to improve endometrial receptivity, so as to increase the embryo implantation numbers in the COH mice model. BSTJD could coordinate with VEGFA to upregulate KLF4 level, which increased HEMECs proliferation and migration and decreased cell apoptosis via improving mitochondrial function. BSTJD promoted KLF4-GCN5 complex formation via activating the ERK pathway. This complex was recruited to the KLF4-binding site of the VEGFA promoter in HEMECs and transactivated VEGFA expression, leading to endometrial angiogenesis. CONCLUSIONS: BSTJD improves endometrial receptivity to increase embryo implantation by activating KLF4, which not only promotes angiogenesis through improving mitochondrial function but also strengthens the KLF4-GCN5 interaction to activate VEGFA transcription.

来源:J Ethnopharmacol,查看原文。版权归原作者所有。

引用

  1. Cao C, Li J, Zhang Y, et al. Bushen Tiaojing Decoction promotes endometrial angiogenesis to improve endometrial receptivity by regulating KLF4-mediated mitochondrial function and transcription activity. J Ethnopharmacol. 2025. PMID: 41033423. doi:10.1016/j.jep.2025.120658

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。